Oral Session 3-13D ITP

[OS3-13D-3] HDD as the initial treatment for ITP: a multicenter, open-label, single arm trial

Ken Takase¹, Hirokazu Nagai², Takanori Yoshioka⁴, Nobuyuki Yoshio⁵, Yukio Hirabayashi⁶, Takuo Ito⁷, Morio Sawamura⁸, Akihiro Yokoyama⁹, Shinichiro Yoshida¹⁰, Ikuyo Tsutsumi¹¹, Maki Otsuka¹², Yoko Suehiro¹³, Michihiro Hidaka¹⁴, Isao Yoshida¹⁵, Hisayuki Yokoyama¹⁶, Hitoshi Inoue¹⁷, Hiroatsu Iida², Maki Nakayama¹⁸, Terutoshi Hishita¹⁹, Hiromi Iwasaki¹, Yoshiaki Kuroda³ (1.Hematol., NHO Kyushu Medical Center. Fukuoka, Japan, 2.Hematol., NHO Nagoya Medical Center, Nagoya, Japan, 3.Hematol., NHO Hiroshima-Nishi Medical Center, Otake, Japan, 4.Hematol., NHO Okayama Medical Center, Okayama, Japan, 5.Hematol., NHO Kanazawa Medical Center, Kanazawa, Japan, 6.Hematol., NHO Matsumoto Medical Center, Matsumoto, Japan, 7.Hematol., NHO Kure Medical Center, Kure, Japan, 8.Hematol., NHO Shibukawa Medical Center, Shibukawa, Japan, 9.Hematol., NHO Tokyo Medical Center, Tokyo, Japan, 10.Hematol., NHO Nagasaki Medical Center, Omura, Japan, 11.Hematol., NHO Mito Medical Center, Ibaraki-gun, Japan, 12.Hematol., NHO Kagoshima Medical Center, Kagoshima, Japan, 13.Hematol., NHO Kyushu Cancer Center, Fukuoka, Japan, 14.Hematol., NHO Kumamoto Medical Center, Kumamoto, Japan, 15.Hematol Oncol., NHO Shikoku Cancer Center, Matsuyama, Japan, 16.Hematol., NHO Sendai Medical Center, Sendai, Japan, 17.Internal., NHO Tsuruga Medical Center, Tsuruga, Japan, 18.Hematol., NHO Nishi-Beppu National Hospital, Beppu, Japan, 19.Hematol., NHO Himeji Medical Center, Himeji, Japan)